Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2006. MMWR 2006;55(No. RR-11):1-94.

Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, Feigal EG, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2000;93:824-42.

Jones RW, Rowan EM. Spontaneous regression of vulvar intraepithelial neoplasia 2-3. Obstet Gynecol 2000;96:470-2.

Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006;197:1018-22.

Le T, Menard C, Hicks-Boucher W, Hopkins L, Weberpals J, Fung-Kee-Fung M. Final results of a phase 2 study using continuous 5% imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia. Gynecol Oncol 2007;106:579-84.

Mathiesen O, Buus SK, Cramers M. Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomized, double-blinded study. Gynecol Oncol 2007;1-7:219-22.

Scurry J, Wilkinson EJ. Review of terminology of precursors of vulvar squamous cell carcinoma. J Lower Genital Tract Dis 2006;10:161-9.

Stanley M. Chapter 17: Genital human papillomavirus infections-current and prospective therapies. J Natl Cancer Inst Monogr 2003;31:117-24.

van Seters M, van Beurden M, de Craen AJ. Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3,322 published patients. Gynecol Oncol 2005;97:645-51.